In short. Why skin disease can signal disease elsewhere, which organs are at risk, and how multidisciplinary care is organised around one plan.
Key points
- When dermatology, rheumatology, respiratory medicine, renal medicine and pathology work in one institution, a referral that would otherwise take months can happen in days, and the biopsy, the imaging and the antibody tests are read as one picture.
- For diseases that can move quickly, that matters.
Skin is an organ, and autoimmune disease that selects it does not always stop there. Several of these conditions are systemic by nature: the same immune process that produces a rash can affect joints, muscles, lungs, kidneys, the heart, the blood or the digestive tract. Sometimes the skin is the first sign and the physician looking after the internal organs is called afterwards; sometimes the skin is one part of an illness already under treatment elsewhere. Either way, the skin is often the most visible indicator of what the immune system is doing.
Which organs, and in which conditions
In lupus, the kidneys are the principal concern and urine testing is the simplest way to detect early involvement; joints, blood cells and the nervous system can also be affected. In systemic sclerosis, the lungs, heart, kidneys and digestive tract are at risk, and pulmonary fibrosis and pulmonary hypertension are the leading causes of death. In dermatomyositis, muscle and lung involvement are assessed routinely, and there is an association with an underlying malignancy. In pemphigus and pemphigoid, the danger is not another organ but the skin itself: widespread erosion, fluid loss, infection and poor nutrition. Lichen planus can involve the mouth, genitals and oesophagus, and longstanding oral disease needs specialist surveillance.
How multidisciplinary care works
Multidisciplinary care is not simply several appointments. It means that the clinicians involved share one assessment and one plan, so that treatment given for the skin does not conflict with treatment given for the lungs, and so that everyone knows what the others are watching for. In practice it involves a dermatologist leading the skin disease, a rheumatologist or immunologist where systemic disease dominates, and organ specialists as needed: respiratory physicians for lung disease, kidney specialists for renal involvement, cardiologists, gastroenterologists, and obstetric services where pregnancy is being planned. Nursing, physiotherapy, dietetics, pharmacy and psychology all contribute directly to outcomes.
What patients should expect
Expect coordination rather than duplication: one team aware of everything being prescribed, one clear answer about which medicine is being changed and why, and one point of contact when something goes wrong. Expect monitoring to be scheduled in advance rather than arranged in response to symptoms, because the complications that matter most are the ones that are silent early. And expect to be asked about symptoms outside the skin: breathlessness, difficulty swallowing, joint pain, changes in the urine and fatigue. Those questions are not box-ticking. They are how organ involvement is found early, when treatment works best.
The advantage of a hospital setting
When dermatology, rheumatology, respiratory medicine, renal medicine and pathology work in one institution, a referral that would otherwise take months can happen in days, and the biopsy, the imaging and the antibody tests are read as one picture. For diseases that can move quickly, that matters.
Do not wait on these symptoms
- Breathlessness, a persistent dry cough, or chest pain.
- Blood or protein in the urine, or new swelling of the face, legs or ankles.
- Difficulty swallowing, fever with a flare, or severe unremitting fatigue.
Frequently asked questions
Which organs are at risk in these conditions?
It varies by disease. In lupus the kidneys are the principal concern, and joints, blood cells and the nervous system can also be affected. In systemic sclerosis the lungs, heart, kidneys and digestive tract are at risk. In dermatomyositis, muscle and lung are assessed routinely. In pemphigus and pemphigoid the danger is the skin itself, through erosion and infection.
What does multidisciplinary care actually mean?
It is not simply several appointments. The clinicians involved share one assessment and one plan, so that treatment given for the skin does not conflict with treatment given for the lungs, and so that everyone knows what the others are watching for. A dermatologist leads the skin disease, with rheumatology and organ specialists contributing as needed.
Why is monitoring scheduled in advance rather than arranged when symptoms appear?
Because the complications that matter most are the ones that are silent early. Patients should expect to be asked about breathlessness, difficulty swallowing, joint pain, changes in the urine and fatigue. Those questions are not box-ticking; they are how organ involvement is found early, when treatment works best.
Risks & Limitations
- These are chronic conditions that are managed rather than cured, and flares are expected along the way.
- Immunosuppressive treatment raises the risk of infection and needs regular blood monitoring.
- Long-term systemic corticosteroids carry real side effects, including bone, metabolic and eye complications.
- Steroid-sparing agents and biologics have their own risks, including blood count, liver and kidney effects.
- Treatment is usually long term, and relapse is common when it is reduced or stopped.
- No treatment works for everyone, response cannot be predicted, and nothing here is guaranteed.
- Some scarring, pigment change and hair loss may be permanent even with good control.
When to Seek Care
- Widespread blistering, or raw eroded skin that is spreading — seek urgent care.
- Blistering or erosions in the mouth or throat that make eating or drinking difficult — seek urgent care.
- Fever with a rash, especially while on immunosuppressive treatment.
- Sudden severe skin pain or peeling of the skin — seek emergency care immediately.
- New breathlessness or chest pain, which may indicate involvement beyond the skin — seek emergency care.
References & Further Reading
- American Academy of Dermatology (AAD) — public and clinical guidance
- International Pemphigus & Pemphigoid Foundation — patient and clinical resources
- Cochrane Library — systematic reviews in dermatology
- Chinese Medical Association, Dermatology Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.